0

Blood Glucose Monitoring Market in APAC by Product and Geography - Forecast and Analysis 2022-2026

  • Published: May 2022
  • Pages: 114
  • SKU: IRTNTR73404
Technavio

Purchase this report now and if we publish a new version within 90 days, we will send you a free copy.

Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The blood glucose monitoring market share in APAC is expected to increase by USD 1.62 billion from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 9.05%.

This blood glucose monitoring market in APAC research report extensively covers blood glucose monitoring market segmentation in APAC by:

  • Product - SMBG, CGM, and Lancets
  • Geography - China, India, Japan, and South Korea

The blood glucose monitoring market vendors in APAC are - Abbott Laboratories, ACON Laboratories Inc., Advin Health Care, ARKRAY Inc., Bionime Corp., Dexcom Inc., F. Hoffmann La Roche Ltd., Hangzhou Sejoy Electronics and Instruments Co. Ltd., Johnson and Johnson services Inc., medisana GmbH, Medtronic Plc, Novo Nordisk AS, PHC Holdings Corp., Pulsatom Healthcare Pvt. Ltd., Rossmax International Ltd., SiBionics, Sinocare Inc., WaveForm Technologies Inc., and Zhejiang POCTech Co. Ltd. among others.

What will the Blood Glucose Monitoring Market Size in APAC be During the Forecast Period?

Download the Free Report Sample to Unlock the Blood Glucose Monitoring Market Size in APAC for the Forecast Period and Other Important Statistics

 

Blood Glucose Monitoring Market in APAC: Key Drivers, Trends, and Challenges

The rise in diabetic population is notably driving the blood glucose monitoring market growth in APAC, although factors such as lower diagnosis and treatment rate may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the blood glucose monitoring industry in APAC. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Blood Glucose Monitoring Market Driver in APAC

  • One of the key factors driving growth in the blood glucose monitoring market in APAC is the rise in diabetic population.
  • Obesity, smoking, a sedentary lifestyle, and increased urbanization are all factors leading to the rise in the diabetes population. In addition, the incidence of diabetes is higher in the elderly population.
  • The increasing prevalence of diabetes is driving market expansion. A large increase in the number of patients with type-1 or insulin-dependent type-2 diabetes has been noticed, which has aided in the adoption of these devices in the region.
  • As a result of the rising number of patients with insulin-dependent diabetes, new product introductions by market players are boosting the demand for and adoption of blood glucose monitoring market.

Key Blood Glucose Monitoring Market Trend in APAC

  • The increasing adoption of home healthcare devices is a blood glucose monitoring market trend in APAC that is expected to have a positive impact in the coming years.
  • Diabetes is a chronic disease that can be managed with medicine and a healthy lifestyle. Most people prefer using portable medical equipment such as blood glucose monitoring devices to measure blood glucose levels, which has increased the rate of acceptance of such devices.
  • Blood glucose monitoring devices, such as blood glucose test strips and blood glucose meters, have become an important part of the diabetes care toolkit because they allow for frequent monitoring.
  • Blood glucose test strips and meters can be used at home to provide an accurate blood glucose level reading in a matter of seconds. As a result, patients with diabetes will be able to better manage their disease. This trend is expected to have a strong impact on the blood glucose monitoring market in APAC.

Key Blood Glucose Monitoring Market Challenge in APAC

  • The lower diagnosis and treatment rate will be a major challenge for the blood glucose monitoring market in APAC during the forecast period.
  • One of the major factors resulting in the reduced adoption of blood glucose monitoring market systems, especially in emerging nations, is the presence of a substantial proportion of the population with undiagnosed diabetes.
  • Countries such as China and India have a higher prevalence of delayed diagnosis because chronic diseases such as diabetes mellitus are not well-known among the general public.
  • The lack of traditional procedures by government or commercial entities, as well as limited access to advanced healthcare infrastructure, may hamper market progress.

This blood glucose monitoring market in APAC analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the blood glucose monitoring market in APAC as a part of the global healthcare equipment market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the blood glucose monitoring market in APAC during the forecast period.

Who are the Major Blood Glucose Monitoring Market Vendors in APAC?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

 

  • Abbott Laboratories
  • ACON Laboratories Inc.
  • Advin Health Care
  • ARKRAY Inc.
  • Bionime Corp.
  • Dexcom Inc.
  • F. Hoffmann La Roche Ltd.
  • Hangzhou Sejoy Electronics and Instruments Co. Ltd.
  • Johnson and Johnson services Inc.
  • medisana GmbH
  • Medtronic Plc
  • Novo Nordisk AS
  • PHC Holdings Corp.
  • Pulsatom Healthcare Pvt. Ltd.
  • Rossmax International Ltd.
  • SiBionics
  • Sinocare Inc.
  • WaveForm Technologies Inc.
  • Zhejiang POCTech Co. Ltd.

 

This statistical study of the blood glucose monitoring market in APAC encompasses successful business strategies deployed by the key vendors. The blood glucose monitoring market in APAC is fragmented and the vendors are deploying growth strategies such as focusing on differentiating themselves by offering value-added services and competitive pricing to compete in the market.

Product Insights and News

  • abbott.com - The company offers blood glucose monitoring devices under the brand name Freestyle, that offer a range of features to meet the specific needs of people living with diabetes.

  • abbott.com - Under the established pharmaceuticals products segment, the company manufacturers branded generic pharmaceuticals for established and emerging markets.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The blood glucose monitoring market in APAC forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Blood Glucose Monitoring Market in APAC Value Chain Analysis

Our report provides extensive information on the value chain analysis for the blood glucose monitoring market in APAC, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

What are the Revenue-generating Product Segments in the Blood Glucose Monitoring Market in APAC?

To gain further insights on the market contribution of various segments Request for a FREE sample

The blood glucose monitoring market share growth in APAC by the SMBG segment will be significant during the forecast period. The SMBG segment is organized and will grow rapidly because of the rise in the prevalence of diabetes in APAC. India and China rank high in terms of diabetic populations in the world, and the prevalence of diabetes is expected to increase at a high rate in both countries during the forecast period. With the availability of innovative and advanced SMBG devices, the market is expected to witness a significant rise in the sales of these devices.

This report provides an accurate prediction of the contribution of all the segments to the growth of the blood glucose monitoring market size in APAC and actionable market insights on post COVID-19 impact on each segment.

 

Blood Glucose Monitoring Market Scope in APAC

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 9.05%

Market growth 2022-2026

$ 1.62 billion

Market structure

Fragmented

YoY growth (%)

8.45

Regional analysis

APAC

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Abbott Laboratories, ACON Laboratories Inc., Advin Health Care, ARKRAY Inc., Bionime Corp., Dexcom Inc., F. Hoffmann La Roche Ltd., Hangzhou Sejoy Electronics and Instruments Co. Ltd., Johnson and Johnson services Inc., medisana GmbH, Medtronic Plc, Novo Nordisk AS, PHC Holdings Corp., Pulsatom Healthcare Pvt. Ltd., Rossmax International Ltd., SiBionics, Sinocare Inc., WaveForm Technologies Inc., and Zhejiang POCTech Co. Ltd.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Blood Glucose Monitoring Market in APAC Report?

  • CAGR of the market during the forecast period 2022-2026
  • Detailed information on factors that will drive blood glucose monitoring market growth in APAC during the next five years
  • Precise estimation of the blood glucose monitoring market size in APAC and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the blood glucose monitoring industry in APAC
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of blood glucose monitoring market vendors in APAC

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Read More Read Less

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Country Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 06: Executive Summary – Chart on Incremental Growth
    • Exhibit 07: Executive Summary – Data Table on Incremental Growth
    • Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 09: Parent market
    • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 12: Market segments
  • 3.3 Market size 2021
    • 3.4 Market outlook: Forecast for 2021-2026
      • Exhibit 13: Chart on APAC - Market size and forecast 2021-2026 ($ million)
      • Exhibit 14: Data Table on Regional - Market size and forecast 2021-2026 ($ million)
      • Exhibit 15: Chart on APAC: Year-over-year growth 2021-2026 (%)
      • Exhibit 16: Data Table on Regional - Market size and forecast 2021-2026 ($ million)

    4 Five Forces Analysis

    • 4.1 Five forces summary
      • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
    • 4.2 Bargaining power of buyers
      • Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
    • 4.3 Bargaining power of suppliers
      • Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
    • 4.4 Threat of new entrants
      • Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
    • 4.5 Threat of substitutes
      • Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
    • 4.6 Threat of rivalry
      • Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
    • 4.7 Market condition
      • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

    5 Market Segmentation by Product

    • 5.1 Market segments
      • Exhibit 24: Chart on Product - Market share 2021-2026 (%)
      • Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
    • 5.2 Comparison by Product
      • Exhibit 26: Chart on Comparison by Product
      • Exhibit 27: Data Table on Comparison by Product
    • 5.3 SMBG - Market size and forecast 2021-2026
      • Exhibit 28: Chart on SMBG - Market size and forecast 2021-2026 ($ million)
      • Exhibit 29: Data Table on SMBG - Market size and forecast 2021-2026 ($ million)
      • Exhibit 30: Chart on SMBG - Year-over-year growth 2021-2026 (%)
      • Exhibit 31: Data Table on SMBG - Year-over-year growth 2021-2026 (%)
    • 5.4 CGM - Market size and forecast 2021-2026
      • Exhibit 32: Chart on CGM - Market size and forecast 2021-2026 ($ million)
      • Exhibit 33: Data Table on CGM - Market size and forecast 2021-2026 ($ million)
      • Exhibit 34: Chart on CGM - Year-over-year growth 2021-2026 (%)
      • Exhibit 35: Data Table on CGM - Year-over-year growth 2021-2026 (%)
    • 5.5 Lancets - Market size and forecast 2021-2026
      • Exhibit 36: Chart on Lancets - Market size and forecast 2021-2026 ($ million)
      • Exhibit 37: Data Table on Lancets - Market size and forecast 2021-2026 ($ million)
      • Exhibit 38: Chart on Lancets - Year-over-year growth 2021-2026 (%)
      • Exhibit 39: Data Table on Lancets - Year-over-year growth 2021-2026 (%)
    • 5.6 Market opportunity by Product
      • Exhibit 40: Market opportunity by Product ($ million)

    6 Customer Landscape

    • 6.1 Customer landscape overview
      • Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    7 Geographic Landscape

    • 7.1 Geographic segmentation
      • Exhibit 42: Chart on Market share by geography - 2021-2026 (%)
      • Exhibit 43: Data Table on Market share by geography - 2021-2026 (%)
    • 7.2 Geographic comparison
      • Exhibit 44: Chart on Geographic comparison
      • Exhibit 45: Data Table on Geographic comparison
    • 7.3 China - Market size and forecast 2021-2026
      • Exhibit 46: Chart on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 47: Data Table on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 48: Chart on China - Year-over-year growth 2021-2026 (%)
      • Exhibit 49: Data Table on China - Year-over-year growth 2021-2026 (%)
    • 7.4 India - Market size and forecast 2021-2026
      • Exhibit 50: Chart on India - Market size and forecast 2021-2026 ($ million)
      • Exhibit 51: Data Table on India - Market size and forecast 2021-2026 ($ million)
      • Exhibit 52: Chart on India - Year-over-year growth 2021-2026 (%)
      • Exhibit 53: Data Table on India - Year-over-year growth 2021-2026 (%)
    • 7.5 Japan - Market size and forecast 2021-2026
      • Exhibit 54: Chart on Japan - Market size and forecast 2021-2026 ($ million)
      • Exhibit 55: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
      • Exhibit 56: Chart on Japan - Year-over-year growth 2021-2026 (%)
      • Exhibit 57: Data Table on Japan - Year-over-year growth 2021-2026 (%)
    • 7.6 South Korea - Market size and forecast 2021-2026
      • Exhibit 58: Chart on South Korea - Market size and forecast 2021-2026 ($ million)
      • Exhibit 59: Data Table on South Korea - Market size and forecast 2021-2026 ($ million)
      • Exhibit 60: Chart on South Korea - Year-over-year growth 2021-2026 (%)
      • Exhibit 61: Data Table on South Korea - Year-over-year growth 2021-2026 (%)
    • 7.7 Market opportunity by geography
      • Exhibit 62: Market opportunity by geography ($ million)

    8 Drivers, Challenges, and Trends

    • 8.1 Market drivers
      • 8.2 Market challenges
        • 8.3 Impact of drivers and challenges
          • Exhibit 63: Impact of drivers and challenges in 2021 and 2026
        • 8.4 Market trends

          9 Vendor Landscape

          • 9.1 Overview
            • 9.2 Vendor landscape
              • Exhibit 64: Overview on Criticality of inputs and Factors of differentiation
            • 9.3 Landscape disruption
              • Exhibit 65: Overview on factors of disruption
            • 9.4 Industry risks
              • Exhibit 66: Impact of key risks on business

            10 Vendor Analysis

            • 10.1 Vendors covered
              • Exhibit 67: Vendors covered
            • 10.2 Market positioning of vendors
              • Exhibit 68: Matrix on vendor position and classification
            • 10.3 Abbott Laboratories
              • Exhibit 69: Abbott Laboratories - Overview
              • Exhibit 70: Abbott Laboratories - Business segments
              • Exhibit 71: Abbott Laboratories - Key news
              • Exhibit 72: Abbott Laboratories - Key offerings
              • Exhibit 73: Abbott Laboratories - Segment focus
            • 10.4 ACON Laboratories Inc.
              • Exhibit 74: ACON Laboratories Inc. - Overview
              • Exhibit 75: ACON Laboratories Inc. - Product / Service
              • Exhibit 76: ACON Laboratories Inc. - Key offerings
            • 10.5 ARKRAY Inc.
              • Exhibit 77: ARKRAY Inc. - Overview
              • Exhibit 78: ARKRAY Inc. - Product / Service
              • Exhibit 79: ARKRAY Inc. - Key offerings
            • 10.6 Bionime Corp.
              • Exhibit 80: Bionime Corp. - Overview
              • Exhibit 81: Bionime Corp. - Product / Service
              • Exhibit 82: Bionime Corp. - Key offerings
            • 10.7 Dexcom Inc.
              • Exhibit 83: Dexcom Inc. - Overview
              • Exhibit 84: Dexcom Inc. - Product / Service
              • Exhibit 85: Dexcom Inc. - Key news
              • Exhibit 86: Dexcom Inc. - Key offerings
            • 10.8 F. Hoffmann La Roche Ltd.
              • Exhibit 87: F. Hoffmann La Roche Ltd. - Overview
              • Exhibit 88: F. Hoffmann La Roche Ltd. - Business segments
              • Exhibit 89: F. Hoffmann La Roche Ltd. - Key news
              • Exhibit 90: F. Hoffmann La Roche Ltd. - Key offerings
              • Exhibit 91: F. Hoffmann La Roche Ltd. - Segment focus
            • 10.9 Johnson and Johnson services Inc.
              • Exhibit 92: Johnson and Johnson services Inc. - Overview
              • Exhibit 93: Johnson and Johnson services Inc. - Business segments
              • Exhibit 94: Johnson and Johnson services Inc. - Key news
              • Exhibit 95: Johnson and Johnson services Inc. - Key offerings
              • Exhibit 96: Johnson and Johnson services Inc. - Segment focus
            • 10.10 Medtronic Plc
              • Exhibit 97: Medtronic Plc - Overview
              • Exhibit 98: Medtronic Plc - Business segments
              • Exhibit 99: Medtronic Plc - Key news
              • Exhibit 100: Medtronic Plc - Key offerings
              • Exhibit 101: Medtronic Plc - Segment focus
            • 10.11 PHC Holdings Corp.
              • Exhibit 102: PHC Holdings Corp. - Overview
              • Exhibit 103: PHC Holdings Corp. - Business segments
              • Exhibit 104: PHC Holdings Corp. - Key offerings
              • Exhibit 105: PHC Holdings Corp. - Segment focus
            • 10.12 WaveForm Technologies Inc.
              • Exhibit 106: WaveForm Technologies Inc. - Overview
              • Exhibit 107: WaveForm Technologies Inc. - Product / Service
              • Exhibit 108: WaveForm Technologies Inc. - Key offerings

            11 Appendix

            • 11.1 Scope of the report
              • 11.2 Inclusions and exclusions checklist
                • Exhibit 109: Inclusions checklist
                • Exhibit 110: Exclusions checklist
              • 11.3 Currency conversion rates for US$
                • Exhibit 111: Currency conversion rates for US$
              • 11.4 Research methodology
                • Exhibit 112: Research methodology
                • Exhibit 113: Validation techniques employed for market sizing
                • Exhibit 114: Information sources
              • 11.5 List of abbreviations
                • Exhibit 115: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              TechnavioINFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases
              Technavio

              TechnavioDATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts
              Technavio

              TechnavioREPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape
              Interested in this report?
              Get your FREE sample now!
              The blood glucose monitoring market growth will increase by $1621.36 million during 2022-2026.
              The blood glucose monitoring market is expected to grow at a CAGR of 9.05% during 2022-2026.
              Technavio has segmented the blood glucose monitoring market by product (SMBG, CGM, and Lancets) and geographic (APAC).
              Abbott Laboratories, ACON Laboratories Inc., Advin Health Care, ARKRAY Inc., Bionime Corp., Dexcom Inc., F. Hoffmann La Roche Ltd., Hangzhou Sejoy Electronics and Instruments Co. Ltd., Johnson and Johnson services Inc., medisana GmbH, Medtronic Plc, Novo Nordisk AS, PHC Holdings Corp., Pulsatom Healthcare Pvt. Ltd., Rossmax International Ltd., SiBionics, Sinocare Inc., WaveForm Technologies Inc., Zhejiang POCTech Co. Ltd. are a few of the key vendors in the blood glucose monitoring market.
              APAC will register the highest growth rate of 100% among the other regions. Therefore, the blood glucose monitoring market in APAC is expected to garner significant business opportunities for the vendors during the forecast period.
              The key factors driving the blood glucose monitoring market growth are:
              • Rise in diabetic population

                Obesity, smoking, a sedentary lifestyle, and increased urbanization are all factors leading to the rise in the diabetes population. In addition, the incidence of diabetes is higher in the elderly population. The increasing prevalence of diabetes is driving market expansion. According to the International Diabetes Foundation (IDF), in 2021, 90 million adults were living with diabetes in the South-East Asia region. These numbers are estimated to increase to 113 million by 2030 and 152 million by 2045. A large increase in the number of patients with type-1 or insulin-dependent type-2 diabetes has also been noticed, which has aided in the adoption of these devices in the region.

                As a result of the rising number of patients with insulin-dependent diabetes, new product introductions by market players are boosting the demand for and adoption of blood glucose monitoring market. As a result, market growth is expected during the forecast period.


              • Increasing adoption of home healthcare devices

                Diabetes is a chronic disease that can be managed with medicine and a healthy lifestyle. Most people prefer using portable medical equipment such as blood glucose monitoring devices to measure blood glucose levels, which has increased the rate of acceptance of such devices. blood glucose monitoring devices, such as blood glucose test strips and blood glucose meters, have become an important part of the diabetes care toolkit because they allow for frequent monitoring. Furthermore, frequent blood glucose testing is essential for successful diabetes control. Blood glucose test strips and meters can be used at home to provide an accurate blood glucose level reading in a matter of seconds. As a result, patients with diabetes will be able to better manage their disease. This trend is expected to have a strong impact on the blood glucose monitoring market in APAC during the forecast period.


              The blood glucose monitoring market vendors should focus on grabbing business opportunities from the smbg segment as it accounted for the largest market share in the base year.
              Safe and Secure SSL Encrypted
              Technavio

              Single User:

              2500 USD

              Technavio Get the report (PDF) sent to your email within minutes.

              Subscribe & Save

              Get lifetime access to our
              Technavio Insights

              Want to customize this report?

              This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

              We offer $1000 worth of FREE customization at the time of purchase
              Technavio
              Enquire Before Buying
              1. Home
              2. Health Care
              3. Published Report
              17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>